Clinical Trial

Gamma tACS to Improve Cognitive Function in Mild Cognitive Impairment

Study acronym: TACS-MCI
Completed
View on ClinicalTrials.gov →
Summary
Mild cognitive impairment (MCI) is a decline in memory and thinking that exceeds normal aging but does not substantially disrupt daily life, and it raises the risk of developing dementia. Effective treatments for its cognitive difficulties are few. This study tests whether transcranial alternating current stimulation (tACS), a non-invasive method that delivers a weak oscillating electrical current through scalp electrodes, can improve thinking and memory in older women with MCI. The current oscillates at 80 Hz, a frequency in the gamma range, because gamma brain rhythms support memory and attention and are disrupted in MCI. Thirty older women with MCI are randomly assigned to receive either active 80 Hz tACS or sham (placebo) stimulation. Participants and the person delivering the stimulation do not know the group assignment. Both groups complete the same cognitive tests before and after the sessions, measuring overall cognitive status, planning, visuospatial working memory, and reaction speed. The aim is to determine whether active 80 Hz tACS improves cognitive performance more than sham stimulation.
Trial Details
NCT Number NCT07752316
Lead Sponsor The National Brain Mapping Laboratory (NBML)
Collaborators: Mohaghegh Ardabili University, University Hospital, Aachen
Conditions Mild Cognitive Impairment (MCI)
Enrollment 30 participants
Start Date 2024-03-02
Primary Completion 2025-04-01 (estimated)
Study Completion 2025-10-15 (estimated)
Updated on ClinicalTrials.gov 2026-08-07